What is ProMIS Neurosciences 6-1 Month Momentum %?
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-06), ProMIS Neurosciences's 6-1 Month Momentum % is -28.53%.
The industry rank for ProMIS Neurosciences's 6-1 Month Momentum % or its related term are showing as below:
PMN's 6-1 Month Momentum % is ranked worse than 66.64% of 1475
companies
in the Biotechnology industry
Industry Median: -13.46
vs PMN: -28.53
Competitive Comparison of ProMIS Neurosciences's 6-1 Month Momentum %
For the Biotechnology subindustry, ProMIS Neurosciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProMIS Neurosciences's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ProMIS Neurosciences's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where ProMIS Neurosciences's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
ProMIS Neurosciences 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of ProMIS Neurosciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PMN has been successfully added to your